Physician profile
Daniel J Heintz
NPI 1649258484
$2,581.53
in general payments reported to CMS, 2019-2025
25 companies · $57.54 in 2025
The $57.54 reported for 2025 was less than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $749 · 2020: $157 · 2021: $178 · 2022: $624 · 2023: $503 · 2024: $313 · 2025: $57.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $873.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $312.21 | 2019-2024 | |
| Sobi, INC | $251.03 | 2019-2023 | |
| Pharming Healthcare, INC. | $206.06 | 2022-2024 | Ruconest, Joenja |
| Alcresta Therapeutics, INC. | $185.98 | 2022-2023 | Relizorb |
| Philips North America LLC | $185.37 | 2019-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $178.17 | 2022-2025 | |
| Glaxosmithkline, LLC. | $148.22 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $147.51 | 2019-2022 | |
| Biogen, INC. | $135.39 | 2021-2024 | Spinraza |
| Gilead Sciences, INC. | $133.38 | 2019-2021 | |
| Baxter Healthcare | $118.20 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Chiesi USA, INC. | $105.10 | 2019-2022 | |
| Allergan, INC. | $96.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $79.66 | 2019-2025 | Tezspire, Fasenra |
| Phadia US INC. | $61.70 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $41.03 | 2021 | |
| Genentech USA, INC. | $36.81 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.46 | 2023 | |
| Breas Medical, INC. | $22.52 | 2024 | Vivo 45 Ls |
| Tactile Systems Technology INC | $22.44 | 2024 | Flexitouch Plus, Entre Plus |
| Ambu INC. | $18.14 | 2023 | |
| Electromed, INC. | $17.80 | 2019 | |
| Monaghan Medical Corporation | $17.42 | 2019 | |
| Mylan Specialty L.P. | $15.76 | 2020 | |
| Circassia INC. | $14.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Heintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.